Literature DB >> 29182106

Multidisciplinary approach to osteosarcoma.

A Biazzo, M De Paolis.   

Abstract

Osteosarcoma is a malignant bone tumor composed of mesenchymal cells producing osteoid and immature bone. Osteosarcoma is the most frequent primary malignant bone tumor, if we excluded myeloma, a haematologic disease. The incidence of osteosarcoma is 2-3/million/year, but is higher in adolescence, in which the annual incidence peaks at 8-11/million/year at 15-19 years of age. Local pain, followed by localized swelling and limitation of joint movement, are the typical signs and symptoms. Correct diagnosis can be achieved through a correct approach to the disease and the combination of clinical and radiographic aspects. The final step to confirm the diagnosis is the biopsy. Computer Tomography of the chest and Positron-Emission Tomography are mandatory to complete the staging, which is performed according the Musculoskeletal Tumor Society staging system. A multidisciplinary approach is needed both to get to a correct diagnosis (orthopaedic surgeon, radiologist and histopathologist) and to perform definitive treatment. Multidisciplinary approach should be performed in reference centers able to provide access to the full spectrum of care and where orthopaedic surgeon, oncologist, histopathologist, radiologist and radiotherapist can cooperate. The management of osteosarcoma is based primarily on neo-adjuvant and adjuvant chemotherapy and surgical resection; radiotherapy is not effective as osteosarcomas are relatively radioresistant. Prognostic factors include metastases at presentation, histologic response to induction chemotherapy, the site of the primary tumor (with axial lesions having an inferior outcome), serum lactate dehydrogenase and alkaline phosphatase levels.

Entities:  

Mesh:

Year:  2016        PMID: 29182106

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  68 in total

1.  The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.

Authors:  You Zhou; Ling Yin; Hui Li; Li-Hong Liu; Tao Xiao
Journal:  Cancer Biol Ther       Date:  2019-04-12       Impact factor: 4.742

2.  Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways.

Authors:  Zhengqi Bao; Xiusong Dai; Peter Wang; Yisheng Tao; Damin Chai
Journal:  Cell Cycle       Date:  2019-05-29       Impact factor: 4.534

3.  [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].

Authors:  Y Hu; D Liang; X Chen; L Chen; J Bai; H Li; C Yin; W Zhong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-10-20

4.  [RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibit apoptosis].

Authors:  Z Liu; F Fang; J Li; G Zhao; Q Zang; F Zhang; J Die
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

5.  S100 calcium-binding protein A10 contributes to malignant traits in osteosarcoma cells by regulating glycolytic metabolism via the AKT/mTOR pathway.

Authors:  Feng Ling; Qifeng Lu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294.

Authors:  Yinxian Chen; Sicheng Zhang; Chuanqing Bai; Zhiye Guan; Wenjian Chen
Journal:  Cancer Manag Res       Date:  2020-07-28       Impact factor: 3.989

7.  Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma.

Authors:  Yi Luo; Anqi Zeng; Aiping Fang; Linjiang Song; Chen Fan; Chenjuan Zeng; Tinghong Ye; Hao Chen; Chongqi Tu; Yongmei Xie
Journal:  Invest New Drugs       Date:  2019-01-25       Impact factor: 3.850

8.  The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.

Authors:  James R Barnett; Panagiotis Gikas; Craig Gerrand; Tim Wr Briggs; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2020-01-04       Impact factor: 2.199

9.  Prevalence of Psychological Distress and Its Risk Factors in Patients with Primary Bone and Soft Tissue Tumors.

Authors:  Masato Ise; Eiji Nakata; Yoshimi Katayama; Masanori Hamada; Toshiyuki Kunisada; Tomohiro Fujiwara; Ryuichi Nakahara; Shouta Takihira; Kohei Sato; Yoshiteru Akezaki; Masuo Senda; Toshifumi Ozaki
Journal:  Healthcare (Basel)       Date:  2021-05-11

10.  Long non-coding RNA X-inactive specific transcript promotes osteosarcoma metastasis via modulating microRNA-758/Rab16.

Authors:  Wei Liu; Qiuping Long; Li Zhang; Dehui Zeng; Bingbing Hu; Wei Zhang; Shengyao Liu; Songyun Deng; Li Chen
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.